1) Devigili G, Rinaldo S, Lombardi R, Cazzato D, Margherita Marchi M, Salvi E, Eleopra R and Lauria G. Diagnostic criteria for small fibre neuropathy in clinical practice and research.BRAIN 2019: 142; 3728–3736. doi:10.1093/brain/awz333
2) Lacour M, Zunder T, Schmidtke K, Vaith P, Scheidt C. Multiple chemical sensitivity syndrome: suggestions for an extension of the US. MCS case definition. Int J Hyg Environ Health. 2005;208:141–151
3) Black,D.W.,Rathe,A., Goldstein,R.B.,1990. Environmental illness. A controlled study of 26 subjects with ‘20th century disease’. J. Am. Med. Assoc. 264,3166–3170.
4) Donadio V, Incensi A, Giannoccaro MP, Cortelli P, Di Stasi V, Pizza F, Jaber MA, Baruzzi A, Liguori R. et al (2012) Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy. J Neuropathol Exp Neurol 71:1000–1008 4.
5) Donadio V, Nolano M, Provitera V, Stancanelli A, Lullo F, Liguori R, Santoro et al (2006) Skin sympathetic adrenergic innervation: an immunofluorescence confocal study. Ann Neurol 59:376–381
6) VanDenKerkhof EG, Stitt L, Clark AJ, Gordon A, Lynch M, Morley-Forster PK, Nathan HJ, Smyth C, Toth C, Ware MA, Moulin DE. Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes. Clin J Pain. 2018 Jan;34(1):30-36. doi: 10.1097/AJP.0000000000000512. PMID: 28481836.
7) Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012 Dec;87(12):1196-201. doi: 10.1016/j.mayocp.2012.10.013. PMID: 23218087; PMCID: PMC3541923.)
8)MCS consensus conference,1999. Multiple chemical sensitivity: a 1999 consensus. Arch. Environ. Health 54,147–149.
9) Kreutzer,R.,2000. Idiopathic environmental intolerance: case definition issues. Occup. Med. 15,511–517.
10) Steinemann A. National Prevalence and Effects of Multiple Chemical Sensitivities. J Occup Environ Med. 2018 Mar;60(3):e152-e156. doi: 10.1097/JOM.0000000000001272. PMID: 29329146; PMCID: PMC5865484.
11) Steinemann A. Prevalence and effects of multiple chemical sensitivities in Australia. Prev Med Rep. 2018 Mar 10;10:191-194. doi: 10.1016/j.pmedr.2018.03.007. PMID: 29868366; PMCID: PMC5984225.
12) Kipen H, Fiedler N, Maccia C, Yurkow E, Todaro J, Laskin D. Immunologic evaluation of chemically sensitive patients. Toxicol Ind Health. 1992 Jul-Aug;8(4):125-35. PMID: 1412479.
13) Bell IR, Schwartz GE, Baldwin CM, Hardin EE, Klimas NG, Kline JP, Patarca R, Song ZY. Individual differences in neural sensitization and the role of context in illness from low-level environmental chemical exposures. Environ Health Perspect. 1997 Mar;105 Suppl 2(Suppl 2):457-66. doi: 10.1289/ehp.97105s2457. PMID: 9167980; PMCID: PMC1469822.
14) De Luca C, Scordo MG, Cesareo E, Pastore S, Mariani S, Maiani G, Stancato A, Loreti B, Valacchi G, Lubrano C, Raskovic D, De Padova L, Genovesi G, Korkina L. Biological Definition of Multiple Chemical Sensitivity from Redox State and Cytokine Profiling and not from Polymorphisms of Xenobiotic-Metabolizing Enzymes. Toxicol. Appl. Pharmacol. 2010;248:285–292.
15) De Luca C, Raskovic D, Pacifico V, Thai JC, Korkina L. The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances. Int J Environ Res Public Health. 2011;8(7):2770-2797. doi:10.3390/ijerph8072770
16) Korkina L, Scordo G, Deeva I, Cesareo E, De Luca C. The chemical defensive system in the pathobiology of idiopathic environment-associated diseases. Curr. Drug Metab. 2009;10:914–931.
17) Dearman RJ, Kimber I. Cytokine profiling and chemical allergy. Toxicol. Appl. Pharmacol. 2002;185:228–229.
18)Cui X, Lu X, Hiura M, Oda M, Miyazaki W, Katoh T. Evaluation of genetic polymorphisms in patients with multiple chemical sensitivity. PLoS One. 2013 Aug 13;8(8):e73708. doi: 10.1371/journal.pone.0073708. PMID: 23967348; PMCID: PMC3742528.
19)McKeown-Eyssen G, Baines C, Cole DE, Riley N, Tyndale RF, Marshall L, Jazmaji V. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int J Epidemiol. 2004 Oct;33(5):971-8. doi: 10.1093/ije/dyh251. Epub 2004 Jul 15. PMID: 15256524.
20) Black,D.W.,Okiishi,C.,Schlosser,S.,2000a. A nine-year follow-up of people diagnosed with multiple chemical sensitivities. Psychosomatics 41,253–261.
21) Black,D.W.,2000b. The relationship of mental disorders and idiopathic environmental intolerance. Occup. Med. 15, 557–570.
22) Buchwald,D., Garrity,D.,1994. Comparison of patients with chronic fatigue syndrome,fibromyalgia,and multiple chemical sensitivities. Arch. Intern. Med. 154,2049–2053.
23) Clauw DJ, Fibromyalgia A Clinical Review. JAMA April 16, 2014 Volume 311, Number 15
24) Marques AP, et al. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356–63
25) Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain. 2013 Nov;154(11):2310-6. doi: 10.1016/j.pain.2013.06.001. Epub 2013 Jun 5. PMID: 23748113; PMCID: PMC3845002.
26) Kosmidis ML, Koutsogeorgopoulo L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, et al. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci 2014;347:143–147
27) Giannoccaro MP, Donadio V, Incensi A, Avoni P, Liguori R. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 2014;49:757–759.
28) Uçeyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136(Pt 6):1857–1867.
29) Lawson VH, et al. Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy. Muscle Nerve. 2018
30) Serra J, Collado A, Sola R, Antonelli F, Torres X, Salgueiro M, et al. Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol 2014;75: 196–208.
31) Cleare AJ, Reid S, Chalder T, Hotopf M, Wessely S (2015). Chronic fatigue syndrome. BMJ Clin Evid 28; pii: 1101.
32) Truini A, Biasiotta A, Di Stefano G, Leone C, La Cesa S, Galosi E, Piroso S, Pepe A, Giordano C, Cruccu G. Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain? Pain. 2014 Apr;155(4):828-832
33) Nolano M, Provitera V, Manganelli F, Iodice R, Caporaso G, Stancanelli A, Marinou K, Lanzillo B, Santoro L, Mora G. Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy. Neuropathol Appl Neurobiol. 2017 Feb;43(2):119-132. doi: 10.1111/nan.12332. Epub 2016 Jul 7. PMID: 27288647.
34)Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, Hsieh ST. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. 2004 Jul;127(Pt 7):1593-605. doi: 10.1093/brain/awh180. Epub 2004 May 5. PMID: 15128619.
35)Løseth S, Stålberg E, Jorde R, Mellgren SI. Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol. 2008 Aug;255(8):1197-202. doi: 10.1007/s00415-008-0872-0. Epub 2008 Jun 27. PMID: 18574618.
36) Donadio V, Liguori R. Microneurographic recording from unmyelinated nerve fibers in neurological disorders: an update. Clin Neurophysiol. 2015 Mar;126(3):437-45.